Registry Study on Safety and Outcomes of AtriCure Devices for Treating Inappropriate Sinus Tachycardia and Postural Tachycardia Syndrome

What this Trial Is About

This registry collects real-world safety and performance data on AtriCure devices used to treat Inappropriate Sinus Tachycardia IST and Postural Tachycardia Syndrome POTS. It is both retrospective and prospective, involving multiple centers in the US and internationally. The goal is to understand how these devices are used and their outcomes in typical clinical settings. Participants have undergone or are scheduled to undergo a hybrid epicardial and endocardial ablation procedure using commercially available AtriCure devices. The registry observes these treatments as delivered in routine care without altering clinical decisions. Data collection includes outcomes over a 12-month period following device use for IST or POTS treatment. During participation, researchers collect information on treatment details, safety, and effectiveness from medical records and follow-up visits. The main measurement is device performance and patient outcomes over one year. Participants provide informed consent, and data is gathered both retrospectively and prospectively. The study runs until January 2027, capturing ongoing real-world clinical experiences.

Inappropriate Sinus Tachycardia Registry